Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
OHSU researchers found immune response to COVID-19 strengthens over time
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Milestones in CRISPR
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
Special drone collects environmental DNA from trees
On Jan. 19, 2023, researchers at ETH Zurich and the Swiss Federal research institute WSL announced they had…
USDA researchers developed naturally fire-resistant cotton lines
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
Biotechnology | HIV | NIH | Vaccine
Experimental HIV vaccine regimen safe but ineffective, study found
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
Moderna announced mRNA-1345, an investigational RSV Vaccine, met primary efficacy endpoints in phase 3 trial
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
Three grizzly bears tested positive for highly pathogenic avian influenza in Montana
On Jan. 17, 2023, the Montana Fish and Wildlife Commission (FWP) reported that juvenile grizzly bears tested positive…
University of Wisconsin and TGen researchers used machine learning to make early detection of cancerm more accessible
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
Roche announced EC approval of Xofluza for treatment and prevention of influenza in children aged one year and above
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
Single booster dose with updated bivalent COVID-19 vaccine provides broad protection against COVID-19 including Omicron variant
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
Paxlovid reduced serious risks from Omicron variants
On Jan. 10, 2023, the U.S. National Institutes of Health (NIH) reported that antiviral treatments can help reduce…
United Nations reported that a child or youth died once every 4.4 seconds in 2021
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
BD, CerTest Biotec announced Emergency Use Authorization for Mpox diagnostic test
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Therapeutics
FDA granted accelerated approval for Alzheimer’s disease treatment
On Jan. 6, 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval…
Spanish, Italian and French Health Authorities expanded recommendations for use of Novavax COVID-19 vaccine
On Jan. 5, 2023, Novavax announced that Spain’s Public Health Commission, Italy’s Ministry of Health, and France’s Haute…
NIH launched Home Test to Treat, a pilot COVID-19 telehealth program
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
New approach successfully traced genomic variants back to genetic disorders
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
BioNTech announced strategic partnership with UK Government to provide up to 10,000 patients with personalized mRNA cancer immunotherapies
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
NIH study linked specific outdoor air pollutants to asthma attacks in urban children
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Biotechnology | CRISPR | Disease | Prehistory | Therapeutics
2.6 billion-year-old ancestors of the CRISPR gene-editing tool were resurrected
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
Study reported major reservoir of resistance in wastewater of Southeast Asia, Western Pacific
On Jan. 1, 2023, a study published in the Lancet reported that concentrations of antibiotic residues found in…
Biotechnology | Cartoons - Original | Disease | Life Science History | Polio | Therapeutics | Vaccine
Milestones in Polio
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approves Genentech’s updated drug labeling for Xeloda (capecitabine) under Project Renewal Pilot Program
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
BioNTech and Fosun Pharma announced regulatory approval of mono- and bivalent COVID-19 vaccine COMIRNATYﾮ in individuals 12 years and older in Hong Kong
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
NIH researchers used 3D bioprinting to create eye tissue
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
Sunlenca (lenacapavir) received FDA approval as first-in-class, twice-yearly treatment option for people with multi-drug resistant HIV
On Dec. 22, 2022, Gilead Sciences announced that Sunlenca (lenacapavir), in combination with other antiretroviral(s) (ARV), had been…